First-Line Treatment Patterns of Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC) with and without BRAF Mutations in the US

被引：0
|
作者：
Vieira, M. Cecilia [1 ]
Duncan, K. [1 ]
Hsu, W. -C. [2 ]
Ross, R. [2 ]
Benjumea, D. [2 ]
Vlahiotis, A. [1 ]
Li, B. [1 ]
Wilner, K. D. [3 ]
机构：
[1] Pfizer Inc, New York, NY USA
[2] Genesis Res LLC, Hoboken, NJ USA
[3] Pfizer Inc, San Diego, CA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP01.61
引用
收藏
页码：E36 / E36
页数：1
相关论文
共 50 条
  • [31] COGNITIVE CONCERNS AND PERFORMANCE IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER (mNSCLC)
    Eggen, Annemarie
    Richard, Nadine
    Shen, Gerald
    Shultz, David
    Leighl, Natasha
    Liu, Geoffrey
    Sun, Alexander
    Bosma, Ingeborg
    Reyners, Anna
    Jalving, Mathilde
    Rodin, Gary
    Edelstein, Kim
    NEURO-ONCOLOGY, 2019, 21 : 159 - 159
  • [32] Afatinib: A first-line treatment for selected patients with metastatic non-small-cell lung cancer
    Engle, Jeff
    Kolesar, Jill
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (22) : 1933 - 1938
  • [33] Atezolizumab for first-line treatment of metastatic nonsquamous non-small cell lung cancer: what makes the difference?
    Bersanelli, Melissa
    Petrelli, Fausto
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S3241 - S3243
  • [34] Mefatinib as first-line treatment of patients with advanced non-small cell lung cancer harboring rare EGFR mutations.
    Wang, Pingli
    Cao, Liming
    Tian, Panwen
    Ren, Shengxiang
    Miao, Liyun
    Zhou, Chengzhi
    Fan, Yun
    Li, Yuping
    Lv, Dongqing
    Zhao, Xin
    Yang, Mei
    Zhu, Chaonan
    Xu, June
    Song, Yong
    Wang, Kai
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [35] Docetaxel in combination carboplatin as first-line treatment of patients with inoperable, locally advanced or metastatic non-small cell lung cancer
    Barata, F
    Camacho, E
    Sousa, A
    Costa, MS
    Resende, R
    Meleiro, A
    Nogueira, F
    Pereira, A
    Canário, D
    LUNG CANCER, 2005, 49 : S235 - S235
  • [36] Audit of gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer in patients with EGFR mutation
    Douglas, R.
    Campbell, L.
    McAleese, J.
    Scullin, P.
    LUNG CANCER, 2013, 79 : S9 - S9
  • [37] Chemotherapy beyond first-line in stage IV metastatic non-small cell lung cancer
    Younes, Riad Naim
    Pereira, Jost Rodrigues
    Fares, Abdo Latif
    Gross, Jefferson Luiz
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2011, 57 (06): : 686 - 691
  • [38] First-line Oral Vinorelbine for Elderly or Unfit Patients With Advanced/metastatic Non-small Cell Lung Cancer
    Mansueto, G.
    Longo, F.
    Stumbo, L.
    De Filippis, L.
    Del Signore, E.
    Quadrini, S.
    Del Bene, G.
    Adua, D.
    Lapadula, V.
    Di Seri, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S280 - S280
  • [39] GEFITINIB AS FIRST-LINE THERAPY FOR ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS IN SOUTHERN TAIWAN
    Yang, Cheng-Ta
    Hung, Jen-Yu
    Lai, Chun-Liang
    Hung, Hsin-Chia
    Lai, Yung-Fa
    Lin, Meng-Chih
    Shieh, Jiunn-Min
    Huang, Ming-Shyang
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2010, 26 (01): : 1 - 7
  • [40] Atezolizumab in combination with bevacizumab, paclitaxel and carboplatin for the first-line treatment of patients with metastatic non-squamous non-small cell lung cancer, including patients with EGFR mutations
    Reck, Martin
    Shankar, Geetha
    Lee, Anthony
    Coleman, Shelley
    McCleland, Mark
    Papadimitrakopoulou, Vassiliki A.
    Socinski, Mark A.
    Sandler, Alan
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2020, 14 (02) : 125 - 136
12345